<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1230">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 01, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02053688</url>
  </required_header>
  <id_info>
    <org_study_id>CL001</org_study_id>
    <nct_id>NCT02053688</nct_id>
  </id_info>
  <brief_title>Evaluation Study on Corneal Lens for Vision Correction</brief_title>
  <official_title>Evaluation Study on Corneal Lens for Vision Correction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FORSIGHT Vision3</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FORSIGHT Vision3</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the fitting and visual outcomes of Nexis Lens,
      made of silicone commonly used in the contact lens industry, on healthy eye with or without
      astigmatism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>30 mins</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Astigmatic Correction Lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nexis ACCL lenses vs commercial Toric Lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Toric Soft Contact Lenses</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>commercial toric soft contact lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Astigmatic Correction Lens (Nexis ACCL lenses)</intervention_name>
    <description>Astigmatic refractive error correction</description>
    <arm_group_label>Astigmatic Correction Lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Toric Soft Contact Lenses</intervention_name>
    <description>astigmatism correction using toric optics</description>
    <arm_group_label>Toric Soft Contact Lenses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient with good corneal health

          2. Age 18-65.

          3. Patients able to understand the requirements of the study and willing to follow study
             instructions, to provide written informed consent to participate, and who agree to
             comply with all study requirements.

          4. Best corrected visual acuity of 20/20 or better in the study eye/s

        Exclusion Criteria:

          1. Any other anterior segment abnormality.

          2. No previous corneal procedures, including Laser Vision Correction.

          3. Any abnormalities associated with the eye lids.

          4. Clinically significant inflammation or infection within six (6) months prior to
             study.

          5. Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of
             the Investigator.

          6. Participation in any study involving an investigational drug or device within the
             past 30 calendar days, or ongoing participation in a study with an investigational
             material except studies using corneal lenses.

          7. Intolerance or hypersensitivity to topical anesthetics, fluorescein, or components of
             the material.

          8. Specifically known intolerance or hypersensitivity to contact lenses.

          9. Any condition that, in the opinion of the investigator, would jeopardize the safety
             of the patient.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashley Tuan, OD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nexisvision</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliff Leong</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sara Chiu</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Michelsen</name>
      <address>
        <city>Livermore</city>
        <state>California</state>
        <zip>94550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nexis Vision</name>
      <address>
        <city>Menlo Park</city>
        <state>California</state>
        <zip>94025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nick Chan</name>
      <address>
        <city>San Mateo</city>
        <state>California</state>
        <zip>94401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Josephine Vo-Laurel</name>
      <address>
        <city>Stockton</city>
        <state>California</state>
        <zip>95219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>February 2, 2014</lastchanged_date>
  <firstreceived_date>January 30, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
